Credit Suisse’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $1.28M | Buy |
32,211
+5,467
| +20% | +$217K | ﹤0.01% | 2114 |
|
2023
Q4 | $510K | Buy |
26,744
+11,535
| +76% | +$220K | ﹤0.01% | 2708 |
|
2023
Q3 | $174K | Buy |
+15,209
| New | +$174K | ﹤0.01% | 3042 |
|
2023
Q1 | – | Sell |
-1
| Closed | -$7 | – | 3807 |
|
2022
Q4 | $7 | Sell |
1
-84
| -99% | -$588 | ﹤0.01% | 3773 |
|
2022
Q3 | $1K | Buy |
85
+70
| +467% | +$824 | ﹤0.01% | 3950 |
|
2022
Q2 | $0 | Buy |
+15
| New | – | ﹤0.01% | 4415 |
|
2015
Q4 | – | Sell |
-3,949
| Closed | -$205K | – | 4085 |
|
2015
Q3 | $205K | Buy |
+3,949
| New | +$205K | ﹤0.01% | 3700 |
|